1. ScholarBank@NUS

Ross Andrew Soo

rp03556

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Ross Andrew Soo
(not current staff)
Variants
Ross, S.
Soo, R.
Soo, R.-A.
Soo, R.A.
Soo, Ross
 
Main Affiliation
 
Faculty
 
Email
csiras@nus.edu.sg
 

Publications

Refined By:
File Format:  Adobe PDF
Author:  Goh, Boon Cher
Subject:  Science & Technology

Results 1-11 of 11 (Search time: 0.008 seconds).

Issue DateTitleAuthor(s)
125-Mar-2020A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinomaKong, Li Ren ; Salleh, Nur Afiqah Binte Mohamed ; Ong, Richard Weijie; Tan, Tuan Zea ; Syn, Nicholas L; Goh, Robby Miguel; Fhu, Chee Wei ; Tan, Daniel SW ; Iyer, N Gopalakrishna ; Kannan, Srinivasaraghavan; Verma, Chandra S ; Lim, Yaw Chyn ; Soo, Ross ; Ho, Jingshan ; Huang, Yiqing; Lim, Joline SJ ; Yan, Benedict Junrong; Nga, Min En ; Lim, Seng Gee ; Koeffler, H Phillip ; Lee, Soo Chin ; Kappei, Dennis ; Hung, Huynh The ; Goh, Boon Cher 
21-Mar-2022A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignanciesHo, Jingshan ; Heong, Valerie; Yong, Wei Peng ; Soo, Ross ; Chee, Cheng Ean ; Wong, Andrea ; Sundar, Raghav; Thian, Yee Liang ; Gopinathan, Anil ; Pang, Mei Yan; Koe, Priscillia; Jeraj, Santhiay Nathan; Soe, Phyu Pyar; Soe, Mu Yar; Tang, Tiffany ; Ng, Matthew CH; Tai, David WM ; Tan, Tira JY ; Xu, Hongmei; Chang, Hua; Landesman, Yosef; Shah, Jatin ; Shacham, Sharon; Lee, Soo Chin ; Tan, Daniel SW ; Goh, Boon Cher ; Tan, David SP 
315-Apr-2023A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological MalignanciesChee, Cheng E ; Ooi, Melissa ; Lee, Soo-Chin ; Sundar, Raghav ; Heong, Valerie; Yong, Wei-Peng ; Ng, Chin Hin ; Wong, Andrea; Lim, Joline SJ ; Tan, David SP ; Soo, Ross ; Tan, Joshua TC; Yang, Song; Thura, Min; Al-Aidaroos, Abdul Qader; Chng, Wee Joo ; Zeng, Qi ; Goh, Boon-Cher 
416-Feb-2023Clinical outcome and prognostic factors for Asian patients in Phase I clinical trialsLoh, Jerold; Wu, Jiaxuan; Chieng, Jenny; Chan, Aurora; Yong, Wei-Peng ; Sundar, Raghav ; Lee, Soo-Chin ; Wong, Andrea; Lim, Joline SJ ; Tan, David SP ; Soo, Ross ; Goh, Boon-Cher ; Tai, Bee-Choo ; Chee, Cheng E 
520-May-2020Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma (NPC).Walsh, Robert John; Nickles, Emily Pauline ; Li, Yating ; Dharmadhikari, Bhushan ; Koh, Mickey; Ho, Liam Pock ; Chan, Marieta; Koh, Liang Piu ; Poon, Michelle Li Mei; Tan, Lip Kun ; Huang, Yiqing; Ang, Yvonne Li'en; Chong, Wan Qin; Asokumaran, Yugarajah; Loh, Kwok Seng ; Soo, Ross A ; Lim, Chwee Ming ; Schwarz, Herbert ; Goh, Boon Cher 
618-Oct-2021Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefitNickles, Emily ; Dharmadhikari, Bhushan ; Li, Yating ; Walsh, Robert J; Koh, Liang Piu ; Poon, Michelle ; Tan, Lip Kun ; Wang, Ling-Zhi; Ang, Yvonne; Asokumaran, Yugarajah; Chong, Wan Qin; Huang, Yiqing; Loh, Kwok Seng ; Tay, Joshua ; Soo, Ross ; Koh, Mickey; Ho, Liam Pock ; Chan, Marieta; Niam, Madelaine; Soh, Melissa; Luah, Yen Hoon ; Lim, Chwee Ming ; Kaliaperumal, Nivashini; Au, Veonice B; Talib, Najwa Binte Said Nasir; Sng, Reina ; Connolly, John E ; Goh, Boon Cher ; Schwarz, Herbert 
71-Jul-2015MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell CarcinomaKong, Li Ren ; Chua, Kian Ngiap ; Sim, Wen Jing ; Ng, Hsien Chun ; Bi, Chonglei; Ho, Jingshan ; Nga, Min En ; Pang, Yin Huei ; Ong, Weijie Richard; Soo, Ross Andrew ; Huynh, The Hung ; Chng, Wee Joo ; Thiery, Jean-Paul ; Goh, Boon Cher 
81-Jun-2022Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patientsHuang, Yiqing; Aminkeng, Folefac ; Wong, Alvin SC; Tay, Sen Hee ; Zhao, Joseph J; Ang, Yvonne; Soo, Ross A ; Goh, Boon Cher 
923-Feb-2022Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin +/- Trastuzumab in Advanced Solid TumorsLee, Matilda Xinwei; Wong, Andrea LA ; Ow, Samuel; Sundar, Raghav ; Tan, David SP ; Soo, Ross A ; Chee, Cheng Ean ; Lim, Joline SJ ; Yong, Wei Peng ; Lim, Siew Eng; Goh, Boon Cher ; Wang, Lingzhi ; Lee, Soo Chin 
1030-Sep-2022Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancerHuang, Yiqing; Zhao, Joseph J; Soon, Yu Yang ; Wong, Alvin; Aminkeng, Folefac ; Ang, Yvonne; Asokumaran, Yugarajah; Low, Jia Li; Lee, Matilda; Choo, Joan RE; Chan, Gloria; Kee, Adrian ; Tay, Sen Hee ; Goh, Boon Cher ; Soo, Ross A 
1113-Oct-2021Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patientsHuang, Yiqing; Soon, Yu Yang ; Aminkeng, Folefac ; Tay, Sen Hee ; Ang, Yvonne; Kee, Adrian CL ; Goh, Boon Cher ; Wong, Alvin SC; Soo, Ross A